Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis

Abstract
Quiz Ref ID Dexmedetomidine, a highly selective α2-adrenergic agonist, is a unique sedative agent compared with γ-aminobutyric acid receptor agonists. Dexmedetomidine can improve patients’ ability to communicate pain compared with midazolam and propofol. Therefore, dexmedetomidine is likely to be useful for light sedation.1 The analgesic effects of dexmedetomidine or the reduction of other deliriogenic sedatives may lessen both agitation and delirium.2

This publication has 32 references indexed in Scilit: